Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Next generation patient derived tumor organoids.
Podaza E, Kuo HH, Nguyen J, Elemento O, Martin ML. Podaza E, et al. Transl Res. 2022 Dec;250:84-97. doi: 10.1016/j.trsl.2022.08.003. Epub 2022 Aug 12. Transl Res. 2022. PMID: 35964899 Review.
The synthetic phospholipid C8-C1P determines pro-angiogenic and pro-reparative features in human macrophages restraining the proinflammatory M1-like phenotype.
Ortiz Wilczyñski JM, Mena HA, Ledesma MM, Olexen CM, Podaza E, Schattner M, Negrotto S, Errasti AE, Carrera Silva EA. Ortiz Wilczyñski JM, et al. Among authors: podaza e. Front Immunol. 2023 Jun 16;14:1162671. doi: 10.3389/fimmu.2023.1162671. eCollection 2023. Front Immunol. 2023. PMID: 37398671 Free PMC article.
An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases.
Mordoh A, Aris M, Carri I, Bravo AI, Podaza E, Pardo JCT, Cueto GR, Barrio MM, Mordoh J. Mordoh A, et al. Among authors: podaza e. Front Immunol. 2022 Apr 1;13:842555. doi: 10.3389/fimmu.2022.842555. eCollection 2022. Front Immunol. 2022. PMID: 35432383 Free PMC article. Clinical Trial.
Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood.
Aris M, Bravo AI, Garcia Alvarez HM, Carri I, Podaza E, Blanco PA, Rotondaro C, Bentivegna S, Nielsen M, Barrio MM, Mordoh J. Aris M, et al. Among authors: podaza e. Front Immunol. 2019 Sep 18;10:2213. doi: 10.3389/fimmu.2019.02213. eCollection 2019. Front Immunol. 2019. PMID: 31620131 Free PMC article.
Evaluation of T-Cell Responses Against Shared Melanoma Associated Antigens and Predicted Neoantigens in Cutaneous Melanoma Patients Treated With the CSF-470 Allogeneic Cell Vaccine Plus BCG and GM-CSF.
Podaza E, Carri I, Aris M, von Euw E, Bravo AI, Blanco P, Ortiz Wilczyñski JM, Koile D, Yankilevich P, Nielsen M, Mordoh J, Barrio MM. Podaza E, et al. Front Immunol. 2020 Jun 5;11:1147. doi: 10.3389/fimmu.2020.01147. eCollection 2020. Front Immunol. 2020. PMID: 32582212 Free PMC article. Clinical Trial.
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Colado A, Almejún MB, Podaza E, Risnik D, Stanganelli C, Elías EE, Dos Santos P, Slavutsky I, Fernández Grecco H, Cabrejo M, Bezares RF, Giordano M, Gamberale R, Borge M. Colado A, et al. Among authors: podaza e. Cancer Immunol Immunother. 2017 Apr;66(4):461-473. doi: 10.1007/s00262-016-1946-y. Epub 2016 Dec 23. Cancer Immunol Immunother. 2017. PMID: 28011996 Free PMC article.
The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
Borge M, Remes Lenicov F, Nannini PR, de los Ríos Alicandú MM, Podaza E, Ceballos A, Fernández Grecco H, Cabrejo M, Bezares RF, Morande PE, Oppezzo P, Giordano M, Gamberale R. Borge M, et al. Among authors: podaza e. J Immunol. 2014 Sep 15;193(6):3165-74. doi: 10.4049/jimmunol.1400547. Epub 2014 Aug 15. J Immunol. 2014. PMID: 25127862
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Risnik D, Colado A, Podaza E, Almejún MB, Elías EE, Bezares RF, Fernández-Grecco H, Seija N, Oppezzo P, Borge M, Gamberale R, Giordano M. Risnik D, et al. Among authors: podaza e. Cancer Immunol Immunother. 2020 May;69(5):813-824. doi: 10.1007/s00262-020-02513-y. Epub 2020 Feb 13. Cancer Immunol Immunother. 2020. PMID: 32055920 Free PMC article.
25 results